Idexx Laboratories
IDXX
350 hedge funds and large institutions have $6.55B invested in Idexx Laboratories in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 112 increasing their positions, 131 reducing their positions, and 35 closing their positions.
3% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 35
3% less capital invested
Capital invested by funds: $6.75B → $6.55B (-$199M)
2% less funds holding
Funds holding: 356 → 350 (-6)
15% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 131
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
40% less call options, than puts
Call options by funds: $2.81M | Put options by funds: $4.67M
Top Buyers
Top Sellers
IDXX Hedge Fund Activity: Q4 2015 in Review
350 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2015, worth a combined $6.55B — down 2.9% from $6.75B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of IDXX and 34 opened new positions — a net loss of 1 holder — while 131 trimmed existing stakes and 112 added.
The largest buyer was Fundsmith LLP, adding an estimated $115M. The largest seller was Royce & Associates, cutting an estimated $40.2M.
- 350 institutional investors held Idexx Laboratories (IDXX) as of Q4 2015, down from 356 in Q3 2015.
- Funds reported $6.55B of Idexx Laboratories stock for Q4 2015, down 2.9% quarter-over-quarter.
- 34 funds opened new Idexx Laboratories positions in Q4 2015 and 35 closed out, a net change of -1 holder.
- The largest Idexx Laboratories buyer in Q4 2015 was Fundsmith LLP, an estimated $115M added.
- The largest Idexx Laboratories seller in Q4 2015 was Royce & Associates, an estimated $40.2M sold.
Based on aggregated 13F filings for Q4 2015.